SCHEMBL2994318

SCHEMBL2994318

CNC(=O)c1cc2c(s1)c(C1CCCCC1)c(-c1ccc(Cl)cc1)n2CC(=O)N1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.42
EGFR P00533 2/20 0.42
TYMS P04818 2/20 0.42
LTA4H P09960 2/20 0.42
VDR P11473 2/20 0.42
SRC P12931 2/20 0.42
CTSK P43235 2/20 0.42
F10 P00742 1/20 0.36
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
TACR1 P25103 2/20 0.35
MAPT P10636 2/20 0.35
STAT3 P40763 2/20 0.35
NOTUM Q6P988 1/20 0.35
HTT P42858 1/20 0.35
MMP12 P39900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994921 0.90 EGFR (0.42) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2997041 0.90 MAPK1 (0.44) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2991919 0.90 MAPK1 (0.39) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL5238339 0.85 MAPK1 (0.42) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2994319 0.83 MAPK1 (0.44) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2996624 0.83 MAPK1 (0.44) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2988730 0.82 MAPK1 (0.43) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL424159 0.81 GRIN1 (0.46) GRIN1GRIN2BKDM4EALDH1A1HPGD
SCHEMBL2997172 0.81 RAB9A (0.38) MAPK1EGFRTYMSLTA4HVDR
SCHEMBL2995703 0.80 ALDH1A1 (0.38) MAPK1EGFRTYMSLTA4HVDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US claimed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US claimed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP claimed
JP-2007505091-A 2007-03-08 JP claimed
EP-1664059-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2006-06-07 EP claimed
WO-2005023819-A1 THIENOPYRROLES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-03-17 WO claimed
US-7781431-B2 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2010-08-24 US disclosed
US-20090036443-A1 Thienopyrroles as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2009-02-05 US disclosed
EP-1664059-B1 THIENOPYRROLES AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2007-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036443-A1 Thienopyrroles as antiviral agents ZC3HAV1, XDH, TPMT MAPK1 3424/4885EGFR 3850/4885TYMS 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.